KSH Holdings LimitedSupplemental Joint Venture Agreement • September 29th, 2011
The board of directors (the “Board”) of KSH Holdings Limited (the “Company”, and collectively with its subsidiaries, the “Group”) refers to its previous announcements dated 8 November 2010, 23 March 2011 and 29 March 2011 (the “Previous Announcements”). All capitalised terms not defined herein shall bear the same meanings ascribed to them in the Previous Announcements.
ContractSupplemental Joint Venture Agreement • January 2nd, 2019
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
ContractSupplemental Joint Venture Agreement • January 27th, 2016
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
ContractSupplemental Joint Venture Agreement • August 8th, 2008
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
HO WAH GENTING BERHAD (“HWGB” OR THE “COMPANY”)Supplemental Joint Venture Agreement • November 2nd, 2020
SUPPLEMENTAL JOINT VENTURE AGREEMENT ENTERED INTO BETWEEN HWGB BIOTECH SDN BHD (“HWGB BIOTECH”) (FORMERLY KNOWN AS HWG CONSORTIUM SDN BHD), A WHOLLY-OWNED SUBSIDIARY OF HO WAH GENTING BERHAD AND E-MO BIOLOGY INC. (“EBI”) (“SUPPLEMENTAL JVA”)
ContractSupplemental Joint Venture Agreement • May 7th, 2018
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
